Pamela G. Marrone - 14 Jan 2022 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)

Role
Director
Signature
/s/ Pamela Marrone
Issuer symbol
ATNF
Transactions as of
14 Jan 2022
Net transactions value
+$7,500
Form type
4
Filing time
18 Jan 2022, 15:31:47 UTC
Previous filing
25 Jan 2022
Next filing
28 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATNF Common Stock Award $7,500 +2,467 +247% $3.04 3,467 14 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued in consideration for serving on the Board of Directors and as a Member of the Compensation and Risk, Safety and Regulatory Committees of the Board of Directors, for the quarter ended December 31, 2021. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) pursuant to Rule 16b-3.